Por: CNBC Health March 23, 2023
In this articleA pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021.Adam Glanzman Bloomberg Getty ImagesThe Food and Drug Administration's independent panel of advisors on Wednesday voted against the effectiveness of investigational ALS drug for a rare and aggressive form of the disease.The drug tofersen was developed to treat a rare genetic form of amyotrophic lateral sclerosis, or... + full article
CNBC USA Health March 22, 2023
In this articleA pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021.Adam Glanzman Bloomberg Getty ImagesThe Food and Drug Administration's independent panel of advisors on Wednesday voted against effectiveness of... + más
Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity | Forbes
FDA advisors vote against effectiveness of Biogen's ALS drug for rare and aggressive form of the disease | CNBC
CNBC USA Health March 21, 2023
In this articleA Biogen facility in Cambridge, Massachusetts.Brian Snyder ReutersU.S. Food and Drug Administration staff on Monday said Biogen's investigational ALS drug may have a clinical benefit on a rare and aggressive form of the disease, despite failing a broader... + más
Portland Press Herald USA World March 21, 2023
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., in 2021. Biogen Inc. shares soared after its controversial Alzheimer’s disease therapy was approved by U.S. regulators, a landmark decision that stands to dramatically change treatment for the... + más
Fox Business USA Business December 30, 2022
BioVie president and CEO Cuong Do discusses the positive results of its Parkinson's and Alzheimer's phase 2 trials and explains how its NE3107 drug could reverse the biological clock on 'Varney & Co.' An 18-month-long investigation conducted by the House... + más
Probe: Alzheimer's drug approval 'rife with irregularities' | WPLG Local 10
Probe: Alzheimer's drug approval 'rife with irregularities' | 10 WBNS
Forbes USA Business October 15, 2022
Getty Images Key Takeaways You may have heard the overwhelmingly positive news for Biogen lately—this stock has been a rare winner during a time of extreme volatility in the stock market due to consistent rate hikes. Biogen Inc. (BIBB) is one of the older global biotech... + más
Biogen to pay $900M to settle allegations of improper physician kickbacks | Fox Business
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs | CNBC
ABC7 USA Health September 30, 2022
, has been approved by the US Food and Drug Administration.The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on Thursday. The oral medication can be taken as a standalone therapy or with other treatments, according to the company, and it has been shown... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | ABC News
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
About iurex | Privacy Policy | Disclaimer |